Latest Leadership Changes News

Eureka Group Holdings Limited has reported a robust financial year ending June 2025, with net profit soaring 51.9% and a strategic portfolio expansion in seniors and affordable rental accommodation.

Vault Minerals announces that CEO Luke Tonkin will step down within the next 12 months, triggering a leadership transition as the company continues to build on recent operational successes.

IDT Australia Limited reported a strong 40.6% increase in revenue to $19.86 million for FY25, driven by growth in advanced therapies and contract disbursements. However, the company’s net loss widened to $8.06 million as it transitions from its ‘Rebuild Strategy’ to a new phase focused on sustainable profitability.

Netwealth Group Limited reported robust FY25 results, with Funds Under Administration soaring to $112.8 billion and net profit after tax climbing nearly 40%, underpinned by strong operational leverage and strategic investments.

Qube Holdings Limited reported robust FY25 underlying revenue growth of 27%, driven by strong performances in its Logistics & Infrastructure and Ports & Bulk divisions, while declaring a 71% increase in full-year dividends. Despite challenges including industrial action and weather disruptions, Qube expects continued earnings growth in FY26 supported by strategic acquisitions and operational resilience.

QuickFee Limited posted a 25% increase in revenue to A$25.3 million for FY25, driven by strong growth in both Australia and the US, alongside a positive underlying EBTDA of A$2.4 million before a one-off credit loss provision.

Vault Minerals reports a robust FY25 with A$1.43 billion revenue and a net profit of A$237 million, driven by full-year integration of Silver Lake Resources and operational advances. The company outlines a strategic two-stage expansion at King of the Hills and maintains a strong cash position post debt repayment.

Finbar Group Limited reported a robust 46% increase in revenue to $284.5 million for FY2025, despite a 12.5% decline in comprehensive profit. The company completed key residential projects and sharpened its focus on core property development in Western Australia.

Artrya Limited reported a 17.2% increase in net loss to $16.4 million for FY25, while achieving FDA clearance and launching its AI-driven Salix platform in the U.S. market. The company also secured key commercial partnerships in Australia and raised $20 million in equity funding.

Prescient Therapeutics reported an 11.1% reduction in net loss for FY2025, progressing its lead candidate PTX-100 into Phase 2a trials with FDA Fast Track and Orphan Drug designations, supported by a recent $9.8 million capital raise.

VGI Partners Global Investments Limited reported a $17.6 million net loss for FY25 but maintained its dividend policy and executed a $73 million share buy-back, signaling confidence amid market challenges.

APA Group reported solid FY25 financial results with revenue and EBITDA growth, advanced key infrastructure projects, and meaningful progress on climate targets, while navigating executive leadership transitions.